跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUMAKRAS - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LUMAKRAS
Authorized
STANDARD
LUMAKRAS
Amgen Canada Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
68c7b547fd14f2c5
Company
Amgen Canada Inc
Type
Standard
Approval Details
Approval Id
68c7b547fd14f2c5
Drug Approval Canada Name
LUMAKRAS
Product Name
LUMAKRAS
Status
Marketed
Status Date
2021-10-22
Original Market Date
2021-10-22
Din
02520095
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XX73 SOTORASIB
Atc Name
l 01 xx 73
Aig Number
0163153001
Company Name
Amgen Canada Inc
Company Address
300, 6775 Financial Drive, Mississauga, Ontario, Canada, L5N 0A4
Active Ingredients
SOTORASIB
120 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
68c7b547fd14f2c5
Type
Standard
Back to Health Canada Approvals